Myeloid leukemia


C92personal history of leukemia (Z85.6)
Excludes 2
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)
  • granulocytic leukemia
  • myelogenous leukemia
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

Related Codes

Myeloid leukemia
Acute myeloblastic leukemia
Acute myeloblastic leukemia, not having achieved remission
Acute myeloblastic leukemia, in remission
Acute myeloblastic leukemia, in relapse
Chronic myeloid leukemia, BCR/ABL-positive
Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
Chronic myeloid leukemia, BCR/ABL-positive, in remission
Chronic myeloid leukemia, BCR/ABL-positive, in relapse
Atypical chronic myeloid leukemia, BCR/ABL-negative